News

The company said that they have the final color and taste of the tablet, and managed to meet their end goal of having a tablet that dissolves in

XM02 is a granulocyte colony-stimulating factor (G-CSF) for reducing the duration of severe neutropenia and the incidence of febrile neutropenia, in patients treated with established myelosuppressive chemotherapy for

The acquisition expands Thermo Fisher’s portfolio of reagents and other consumables for the molecular biology research and diagnostics markets through the addition of its proprietary DNA polymerases, Phire

Eric Schmidhaeuser, managing director of Schorndorf operation, said: “We believe the addition of this new potent handling and over-encapsulation area will help to meet the needs of our

Reportedly, SynCo has commenced with preparations for the manufacture of conformance lots in advance of its client’s BLA filings, expected in late 2010, in anticipation of commercial manufacturing

Click4Care’s care management software suite allows payors to aggregate critical patient information to identify the members, who would benefit most from active care management. The software’s functionality offers

Connolly will use InterQual, the gold standard in evidence-based clinical guidelines, as a tool in reviewing the medical necessity portion of RAC audits in the 15 states and

Lehigh Press manufactures labels, inserts and outserts and other packaging components, mainly for the pharmaceutical and healthcare markets. Bill Mitchell, CEO of Keller Crescent, said: “This is a

Actavis became the owner of Norgesplaster in December 2005, following the acquisition of the generics division of Alpharma. Actavis’ focus remains on its core business, generic pharmaceuticals. Actavis